Una Ryan Overview

  • Investor Type
  • Angel

  • Investments
  • 3

  • Portfolio
  • 1

  • Exits
  • 2

Exits

Una Ryan General Information

Description

Dr. Una Ryan serves as the Board Member at Quince Therapeutics. Dr. Una Ryan served as Managing Director at Golden Seeds. She is a Chairperson at Elemental Machines. She is a Board Member of Cortexyme. She is currently a Research Professor of Medicine at BU School of Medicine and serves on its Board of Visitors. Her board positions include AMRI (Lead Director, Nominating and Compensation committees) and MSH (Audit and Compensation committees). She was most recently President and CEO of Diagnostics For All (DFA), a non-profit organization developing inexpensive diagnostics for global health and agricultural uses. Previously, she was President and CEO of AVANT Immunotherapeutics, Inc, (NASDAQ) a company developing vaccines and immunotherapeutics for cancer, travelers, food safety, and global health, and also a member of its Board of Directors. Prior to AVANT, she was director of Health Sciences at Monsanto Company. Before that, she held a number of positions in academia, including Research Professor of Surgery at Washington University School of Medicine in St. Louis and Professor of Medicine at the University of Miami School of Medicine. She was also Chair of the Massachusetts Biotechnology Council and served on its Board, as well as the Biotechnology Industry Organization, New England Healthcare Institute, Board of Associates of the Whitehead Institute, Strategy and Policy Council of the MIT Center for Biomedical Innovation, Massachusetts Life Sciences Collaborative Leadership Council and the Goddard Council on science, technology, engineering, and mathematics education. She holds a Ph.D. in Cellular and Molecular Biology from Cambridge University and BS degrees in Zoology, Microbiology, and Chemistry from Bristol University. She received an Honorary Doctor of Science degree from Bristol University in 2009. In 2007, she received the Albert Einstein Award for outstanding achievement in the life sciences. In 2002 Her Majesty Queen Elizabeth II awarded her the Order of the British Empire (OBE) for services to research, development, and promotion of biotechnology. She is also an Angel Investor. She also served as a Board Member at EMulate Therapeutics.

Business Details

Primary Investor Type
Angel (individual)
Corporate Office
  • 626 Bancroft Way
  • Suite A
  • Berkeley, CA 94710
  • United States
+1 (877) 000-0000

Una Ryan Investments (3)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Respiratory Motion 09-Dec-2015 Later Stage VC 00.000 Monitoring Equipment Generating Revenue 000 0000 00.0
Stanza 09-Apr-2015 0000 00000 00.00 Business/Productivity Software Generating Revenue 000 0000 00.0
Riffyn 18-Sep-2014 0000 00000 00.00 Business/Productivity Software Out of Business 000 0000 00.0

Una Ryan Exits (2)

Company Name Exit Date Exit Type Exit Size
Riffyn 07-Jul-2022 Out of Business
Respiratory Motion 01-Jul-2022 000000000000000000 0000

Una Ryan Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Una Ryan Team (1)

Name Title Deals Funds Boards Office
Una Ryan Ph.D Angel Investor 0 0 0 Berkeley, CA

Una Ryan FAQs

  • Who is Una Ryan?

    Una Ryan is an angel Investor who has made 3 investments.

  • What kind of investor is Una Ryan?

    Una Ryan is an angel investor.

  • What does Una Ryan do?

    As an angel investor, Una Ryan invests personal money into promising companies, typically in exchange for equity.

  • How many board seats does Una Ryan hold?

    Una Ryan holds 3 board seats including Quince Therapeutics, Bell Biosystems, and Elemental Machines.

  • What has Una Ryan invested in?

    Una Ryan has made numerous investments in companies like Respiratory Motion, Stanza, and Riffyn within the Monitoring Equipment and Business/Productivity Software industries.

  • What has Una Ryan invested in recently?

    Una Ryan's latest investment was on 09-Dec-2015 in Respiratory Motion, a company within the Monitoring Equipment industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »